Global Pressure Ulcer Diagnostics Market By Diagnostic (Imaging Techniques, Microbiological Tests, Other Diagnostic Tests), By End-User (Hospitals, Nursing Homes, Homecare Settings, Other End-Users), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

Pressure ulcers, commonly known as bedsores or pressure sores, are skin and tissue lesions produced mostly by continuous pressure on the skin. Pressure ulcers range in severity from discolored patches to open lesions exposing the underlying bone or muscle.

Heels, elbows, hips, and the base of the spine are frequent sites for pressure ulcers. Individuals with mobility issues are more likely to develop pressure ulcers. Due to variables such as reduced aging of the skin, blood flow. Elderly individuals face a greater proportion of mobility problems, with people over the age of 70 being particularly sensitive to pressure ulcers.

Primary driving factors in the pressure ulcer treatment market are technical developments in wound care therapy and an increase in geriatric populations.

Request Covid - 19 Impact

Detailed Segmentation –

Based on Diagnostic Test:

• Imaging Techniques
• Microbiological Tests
• Other Diagnostic Tests

Based on End-User:

• Hospitals
• Nursing Homes
• Homecare Settings
• Other End-Users

Based on Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics –

Drivers for the Global Pressure Ulcer Diagnostics Market:

A significant increase in the senior population living with impairments, a quickly surging prevalence of pressure ulcers, and the increased acceptance of new wound care devices for their treatment are factors expected to augment this market. Owing to surging awareness about the availability of treatment options for pressure ulcers, and an increase in healthcare expenditures, as well as improved treatment processes, are expected to developed the pressure ulcer treatment market over the forecast period.

Additionally, an increase in the desire for multiple treatment options by patients diagnosed globally is expected to boost the pressure ulcer market’s overall size.

Restraints Global Pressure Ulcer Diagnostics Market:

High treatment costs and adverse reimbursement rules are expected to potentially stymie this market’s expansion and poses new challenges to the pressure ulcer diagnostics market.

Opportunities for the Global Pressure Ulcer Diagnostics Market:

A surge in the number of patients with pressure ulcers, booming geriatric populations, an increase in the adoption of artificial skin substitutes, increasing healthcare expenditures, improved government funding, as well as public-private-sector initiatives to raise awareness about the negative impacts of pressure ulcers on a patient’s health and quality of life are factors anticipated to lead to the expansion of the pressure ulcer treatment market.

The pressure ulcer treatment market will benefit from increased research & development activities, high unmet demands, as well as the development of treatment and diagnostic technologies.

Trends for the Global Pressure Ulcer Diagnostics Market:

With the development of innovative technologies for diagnosis and management of illnesses, technological advancements are expected to generate a paradigm shift in the global pressure ulcer diagnostics market. Fluorescence imaging techniques used at the point-of-treatment are widely used and popular to determine the location and presence of bacteria in afflicted areas. This imaging approach is sensitive and precise in determining the number of bacteria in a wound.

Competitive Landscape –

• Arjo Inc.
• Cyberdyne Inc.
• MolecuLight Inc.
• Mölnlycke Health Care AB
• ConvaTec Group PLC
• Braun Melsungen AG
• Integra LifeSciences Corporation
• Covidien
• IR MED
• Bruin Biometrics LLC.

Recent Developments of Major Players –

• In May 2021, RCSI (Royal College of Surgeons in Ireland) and Bruin Biometrics collaborative relationship to innovate the pressure ulcer prevention portfolio was renewed. Bruin Biometrics pressure ulcer prevention portfolio will be expanded as a result of this agreement.
• In July, 2021, Esaote SPA installed its new G-scan Brio machine at Istituto Oncologico del Mediterraneo in Viagrande, Catania, Sicily (IOM). This is a novel strategy that would improve the product's diagnostic capability for a variety of situations.

For the Pressure Ulcer Diagnostics Market research study, the following years have been considered to estimate the market size: